The results suggested that BTN3A1 may have a role in shaping the immunosuppressive tumor microenvironment and may sever as a tumor suppressor in breast cancer and NSCLC by promoting the invasion of innate and adaptive immune cells and inhibition of the invasion of MDSCs. This evidence concerns the gene BTN3A1 and neoplasm.